Skip to main content
SpringerLink
Log in

Preventing and Managing Drug-Induced Anaphylaxis

  • Practical Drug Safety
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Drug-induced anaphylaxis and anaphylactoid reactions have increased in frequency with more widespread use of pharmaceutical agents. Anaphylaxis is a systemic, severe immediate hypersensitivity reaction caused by immunoglobulin (Ig) E-mediated immunological release of mediators of mast cells and basophils. An anaphylactoid reaction is an event similar to anaphylaxis but is not mediated by IgE.

The incidence of anaphylactic or anaphylactoid reactions differs amongst classes of medications. Antibacterials are the most usual offenders, and penicillins are the most studied. Other compounds commonly causing reactions include nonsteroidal anti-inflammatory drugs, anaesthetics, muscle relaxants, latex and radiocontrast media.

Prevention, if possible, is the purpose of detailed patient history taking and physical examination. Simple strategies can be employed to decrease the risk of anaphylaxis. These include consideration of the route of drug administration, identification of patients with known causes of anaphylaxis, and the knowledge that certain medications cross react and are contraindicated in those with known history of anaphylaxis. Tests are available, and include IgE-specific skin tests and radioallergosorbent tests. Penicillins are the only compounds whose antigenic determinants are well documented, it is therefore difficult to determine the negative predictive value of other compounds tested. Oral challenge remains an alternative, though entails risk. Desensitisation procedures, as well as gradual dose escalation protocols, are available and can be implemented based on patient history and diagnostic testing.

The management of anaphylaxis is based on control of the airway, breathing and circulation. Treatment consists of epinephrine (adrenaline) and supportive measures. Rapid diagnosis and intervention are important in these life-threatening reactions. After stabilisation, all individuals with a documented history of anaphylaxis require a Medic-Alert bracelet or necklace, and an identification card for their wallet or purse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Kagy L, Blaiss MS. Anaphylaxis in children. Pediatr Ann 1998 Nov; 27(11): 727–34

    PubMed  CAS  Google Scholar 

  2. Freeman TM. Anaphylaxis: Diagnosis and Treatment. Primary Care; Clinics in Office Practice 1998 Dec; 25(4): 809–17

    Article  PubMed  CAS  Google Scholar 

  3. Hess DA, Rieder MJ. The Role of Reactive Drug Metabolites in Immune-Mediated Adverse Drug Reactions. Ann Pharmacother 1997 Nov; 31(11): 1378–87

    PubMed  CAS  Google Scholar 

  4. Macy E. Elective penicillin skin testing and amoxicillin challenge: Effect on outpatient antibiotic use, cost and clinical outcomes. J Allergy Clin Immunol 1998 Aug; 102(8): 281–5

    Article  PubMed  CAS  Google Scholar 

  5. Lieberman P. Anaphylaxis and Anaphylactiod Reactions. In: Middleton E, Reed CE, Ellis EF, et al., editors. Allergy principles and practice. St. Louis: Mosby, 1998: 1079–91

    Google Scholar 

  6. Douglas DM, Sukenick E, Andrade WP et al. Biphasic systemic anaphylaxis: An inpatient and outpatient study. J Allergy Clin Immunol 1994 Jun 93(6): 977–85

    Article  PubMed  CAS  Google Scholar 

  7. Atkinson TP, Kaliner MA. Anaphylaxis. Med Clin Nor Am 1992; 76: 841–55

    CAS  Google Scholar 

  8. Boston Collaborative Drug Surveillance Program: Brief reports: drug induced anaphylaxis, JAMA 1973; 224: 613

    Google Scholar 

  9. Porter J, Jick H. Boston Collaborative Drug Surveillance Programs: drug induced anaphylaxis, convulsions, deafness and extrapyramidal symptoms. Lancet 1977; I: 587

    Article  Google Scholar 

  10. Amornmarn L, Bernard L, Kumar N, et al. Anaphylaxis admissions to a university hospital. J allergy Clin Immunol 1992; 89Suppl.: 349

    Google Scholar 

  11. Bresser H, Sander C, Rakoski J. Anaphylactic emergencies in Munich. J Allergy Clin Immunol 1995; 95: 386

    Google Scholar 

  12. Klein JS, Yocum MN. Underreporting of anaphylaxis in a community emergency room. J Allergy Clin Immunol 1995; 95: 637–8

    Article  PubMed  CAS  Google Scholar 

  13. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmstead County: a population-based study. J Allergy Clin Immunol 1999: 104: 452–6

    Article  PubMed  CAS  Google Scholar 

  14. Weiss ME, Atkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy 1988: 18: 515–40

    Article  PubMed  CAS  Google Scholar 

  15. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States. Arch Intern Med 2001; 161: 15–21

    Article  PubMed  CAS  Google Scholar 

  16. Falliers CJ. Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol 1973; 52: 141

    Article  PubMed  CAS  Google Scholar 

  17. Manning ME, Stevenson DD, Mathison DA. Reactions to aspirin and other nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 1992 Mar; 12(3): 611–31

    Google Scholar 

  18. Strom BL, Carson JUL, Morse ML, et al. The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other non-steroidal anti-inflammaotry drugs. Arthritis Rheum 1987; 30: 1142

    Article  PubMed  CAS  Google Scholar 

  19. Settipane GA, Chafee FH, Klein DE. Aspirin intolerance: II. A prospective study in an atopic and normal population. J Allergy Clin Immunol 1974; 53: 200

    Article  PubMed  CAS  Google Scholar 

  20. Kemp SF, Lockey RF, Lieberman P, et al. Anaphylaxis, a review of 266 cases. Arch Intern Med 1995; 155: 1749–54

    Article  PubMed  CAS  Google Scholar 

  21. Laxenaire MC, Moneret-Vautrin DA, Widmer S, et al. Substances anesthesiques responsables de chocs anaphylactiques. Enquete multicentrique francaise. Ann Fr Anesth Reanim 1990; 9: 501–6

    Article  PubMed  CAS  Google Scholar 

  22. Laxenaire MC, Le Groupe d’etude des reactions anaphylactoides peranesthesiques. Substances responsables des chocs anaphylactiques peranesthesiques: troisieme enquete multicentrique francaise (dy1992-1994). Ann Fr Anesth Reanim 1996; 15: 1211–8

    Article  PubMed  CAS  Google Scholar 

  23. Gueant JL, Aimone-Gastin I, Namour F, et al. Diagnosis and pathogenesis of the anaphylactic and anaphylactoid reactions to anaesthetics. Clin Exp Allergy 1998; 28: 65–70

    Article  PubMed  CAS  Google Scholar 

  24. Eggleston ST, Lush LW. Understanding allergic reactions to local anesthetics. Ann Pharmacother 1996; 30: 851–7

    PubMed  CAS  Google Scholar 

  25. Giovannitti JA, Bennett CK. Assessment of allergy to local anesthesia. J Am Dent Assoc 1979; 98(5): 701–6

    PubMed  CAS  Google Scholar 

  26. Lagier F, Vervloet D, Lhermet I et al. Prevalance of latex allergy in operating room nurses. J Allergy Clin Immunol 1993; 90: 319–22

    Article  Google Scholar 

  27. Kelly KJ, Walsh-Kelly CM. Latex allergy: A patient and health care system emergency. J Emerg Nurs 1998 Dec; 24(6): 539–45

    Article  PubMed  CAS  Google Scholar 

  28. Latex Hypersensitivity Committee of the American College of Allergy, Asthma, and Immunology: Latex allergy an emerging health care problem. Ann Allergy Asthma Immunol 1995; 75: 19–21

    Google Scholar 

  29. Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621

    PubMed  CAS  Google Scholar 

  30. Adkinson FN. Drug allergy. In: Middleton E, Reed C, Ellis EF, et al., editors. Allergy principlesand practice. St Louis: Mosby, 1998: 1217

    Google Scholar 

  31. Adkinson NF. Beta-lactam crossreactivity. Clin Exp Allergy 1998; 28(4) 37–40

    PubMed  CAS  Google Scholar 

  32. Craig TJ, Mende C. Common allergic and allergic-like reactions to medications. Postgrad Med 1999 Mar; 105(3): 173–81

    Article  PubMed  CAS  Google Scholar 

  33. Sogn DD, Evans III R, Shepard GM, et al. Results of the National Institutes of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derviatives in hospitalized adults. Arch Intern Med 1992; 152: 1025–32

    Article  PubMed  CAS  Google Scholar 

  34. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998 Jan; 132: 137–43

    Article  PubMed  CAS  Google Scholar 

  35. Vervloet D, Arnaud A, Vellieux P, et al. Anaphylactic reactions to muscle relaxants under general anesthesia. J Allergy Clin Immunol 1979; 63: 348

    Article  PubMed  CAS  Google Scholar 

  36. Lieberman P. Difficult allergic drug reactions. Immunol Allergy ClinNorthAm 1991; 11(1): 331

    Google Scholar 

  37. Wolkenstein P, Revuz J. Drug-induced severe skin reactions. Drug Safety 1995; 13(1): 56–68

    Article  PubMed  CAS  Google Scholar 

  38. Gleckman RA, Borrego F. Adverse reactions to antibiotics. Postgrad Med 1997 Apr; 101(4) 97–108

    Article  PubMed  CAS  Google Scholar 

  39. Valyasevi MA, Van Dellen RG. Frequency of systematic reactions to penicillin skin tests. Ann Allergy Asthma Immunol 2000 Nov; 85(5): 363–5

    Article  PubMed  CAS  Google Scholar 

  40. Gruchalla R. Understanding drug allergies. J Allergy Clin Immunol 2000; 105: 637–44

    Article  Google Scholar 

  41. Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol 1982; 69: 238–44

    Article  PubMed  CAS  Google Scholar 

  42. Gadde J, Spence M, Wheeler B, Adkinson NF. Clinical experience with penicillin skin testing in a large inner city STD clinic. JAMA 1993; 270: 2456–63

    Article  PubMed  CAS  Google Scholar 

  43. Li JTC, Markus PJ, Osmon DR, et al. Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy. Mayo Clin Proc 2000; 75: 902–6

    Article  PubMed  CAS  Google Scholar 

  44. Parker DJ, Parrinello JT, Condemi JJ, et al. Penicillin resensitization among hospitalized patients. J Allergy Clin Immunol 1991; 88: 213–7

    Article  PubMed  CAS  Google Scholar 

  45. Simons PR, Roberts JR, Gu X, et al. Epinephrine absorption in children with history of anaphylaxis. J Allergy Clin Immunol 1998; 101: 33–7

    Article  PubMed  CAS  Google Scholar 

  46. Mayumi H, Kimura S, Asano M, et al. Intravenous cimetidine as an effective treatment for systemic anaphylaxis and acute allergic skin reaction. Ann Allergy 1987; 58: 447–50

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Allergic Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, 55905, USA

    Kerry L. Drain &  Gerald W. Volcheck

Authors
  1. Kerry L. Drain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerald W. Volcheck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerald W. Volcheck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drain, K.L., Volcheck, G.W. Preventing and Managing Drug-Induced Anaphylaxis. Drug-Safety 24, 843–853 (2001). https://doi.org/10.2165/00002018-200124110-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200124110-00005

Keywords

Search

Navigation